How much would you pay to live another ten healthy years? A few thousand rupees for an annual health check-up? A monthly subscription for supplements? Or several lakhs for a personalised longevity programme that promises to tell you how well your body is ageing?
Clearly, people are willing to spend. And an entire industry is springing up to meet that demand.India's longevity economy, estimated at $11.05 billion in 2025, is expected to reach nearly $24 billion, or approximately ₹2 trillion, by 2031. According to Karan Chechi, Founder and CEO of TechSci Research, the industry is growing at around 14 per cent annually, faster than the global average of 10.44 per cent.
Worldwide, the longevity market is projected to grow from $370 billion in 2025 to $676 billion by 2031, according to TechSci Research. The opportunity looks even larger when longevity is defined more broadly. A 2026 Bank of Singapore report estimates the global longevity economy at $3 trillion in 2025, potentially reaching $5.4 trillion by 2034.
But what exactly constitutes this market?Chechi makes an important distinction. The longevity market includes products and services designed to extend healthy life, delay age-related decline and improve quality of life. But it does not include every expense associated with growing old."This is not a measure of the cost of being old," he explains. A wellness-oriented retirement community qualifies; a nursing home providing care for the frail does not. Even diagnostics count only when directed towards improving healthy ageing. The distinction is between the business of ageing well and the cost of ageing itself.
The Business of Ageing Well
The longevity industry is an interesting mix of old businesses finding new customers and new businesses creating entirely new markets.
Take diagnostics. The familiar annual health check-up is being repackaged as preventive healthcare, with increasingly sophisticated tests, biological-age assessments and personalised monitoring.
Nutrition is another big business. Supplements once marketed for vitamin deficiencies are now being sold with promises of better metabolism, stronger muscles, sharper cognition and healthier ageing.
Aesthetics has found a place in this economy too. But there is an important distinction between looking younger and actually being healthier. Regenerative medicine and cellular therapies are attracting interest, although many anti-ageing applications remain experimental.
Then there is senior living, perhaps the least glamorous but one of the most important segments. Companies are developing communities where housing comes bundled with fitness, nutrition, healthcare and opportunities for social engagement.
"The longevity market is not one industry. It is a promise, sold across six or seven industries at once, and the companies that will win are the ones that can prove the promise rather than merely price it," says Chechi.
Why India Is Different
India's opportunity is not simply that it has more older people. It is also about who is beginning to spend on longevity.
The customer may well be a 40-year-old professional who is monitoring her blood sugar, investing in fitness and taking preventive health more seriously. She may also be the person deciding where her ageing parents will live and how they will be cared for.
India currently has around 153 million people aged 60 and above. That number is projected to reach 347 million by 2050. Preventive diagnostics, nutrition and senior living are among the emerging opportunities.
Chechi believes India will build its longevity market differently from the West, relying more on affordable diagnostics and prevention at scale than expensive specialist clinics.There is also India's traditional understanding of wellbeing through yoga, Ayurveda and lifestyle practices. The challenge is to examine these through the lens of modern scientific evidence rather than assume that everything traditional is necessarily effective.
Can Money Buy More Healthy Years?
We are living longer, but not necessarily healthier. In India, life expectancy is around 71 years, while healthy life expectancy is barely 60. That leaves nearly 11 years of potentially compromised health.
Can the longevity industry close this gap? Expensive supplements, sophisticated tests and luxury wellness retreats may promise much, but where is the proof? Chechi believes scientific validation and measurable health outcomes will separate credible businesses from those merely selling the promise of youth.
India's ₹2 trillion longevity opportunity is impressive. But the real question is not how much money the industry makes. It is how many healthy years it adds to our lives.
